| Market Cap | ₹6,330Cr |
| ROE | 6.35% |
| P/E Ratio(TTM) | 42.20 |
| EPS(TTM) | 7.67 |
| P/B Ratio | 2.60 |
| Dividend Yield | 0.15% |
| Industry P/E | 32.50 |
| Book Value | 124.61 |
| Debt to Equity | 0.24 |
| Face Value | 1 |
| Managing Director | Mr. Vishnukant Chaturbhuj Bhutada |
| Founded | 1987 |
| NSE Symbol | SHILPAMED |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 65.11 | ||
| Ajanta Pharma | NA (0.00%) | 36.51 | ||
| Gland Pharma | NA (0.00%) | 34.91 | ||
| Sai Life Sciences | NA (0.00%) | 63.35 |